Edesa Biotech
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -25 | -24 | -43 | |
EBITDA | -1,694 | -1,638 | -1,574 | -917 |
EBIT | -1,720 | -1,663 | -1,617 | -962 |
Net Income | -1,749 | -1,590 | -1,617 | -962 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,750 | -2,333 | -1,517 | -967 |
Cash | 12,361 | 13,896 | 1,563 | 1,037 |
Basic Shares | 7,022 | 5,305 | 3,345 | 3,197 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $ |
Gross Profit | -186 | -183 | -118 | -118 |
EBITDA | -5,983 | -9,222 | -17,429 | -13,223 |
EBIT | -6,169 | -9,222 | -17,548 | -13,342 |
Net Income | -6,170 | -8,374 | -17,548 | -13,343 |
Net Change In Cash | 0 | 0 | 0 | |
Free Cash Flow | -4,890 | -6,636 | -12,284 | -13,671 |
Cash | 1,037 | 5,361 | 7,090 | 7,839 |
Basic Shares | 3,197 | 2,858 | 2,096 | 1,725 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.25 |
2025-03-31 | -$0.30 |
2024-12-31 | -$0.48 |
2024-09-30 | -$0.29 |
